Re: use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations: implications for COX-2 cardiovascular profile.
Tjeerd P van Staa
Pharmacoepidemiology and drug safety
View on PubMed
Anti-Inflammatory Agents, Non-Steroidal
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Presentations referencing similar topics
Deconstructing Non-Steroidal Anti-Inflammatory Drugs ( NSAIDs )
AOASM OMED • Oct 18, 2017
COX-2 inhibitors and cardiovascular risk.
Maureen P Flattery + 1 • Dec 29, 2017
Reducing Preventable Harm From Non-Steroidal Anti-Inflammatory Drugs
Amy Barton Pai • Jun 16, 2018